Tissue arrays have become a cornerstone in cancer research due to their ability to facilitate large-scale validation of molecular biomarkers. In oncology, researchers are often interested in studying the expression patterns of specific genes or proteins across a wide spectrum of tumor samples. For example, immunohistochemistry (IHC) staining on a tissue array can reveal differences in protein expression between malignant and benign tissues or among tumors of different grades and stages. This makes tissue arrays particularly useful in identifying diagnostic markers, prognostic indicators, and potential therapeutic targets. Because the same experimental protocol can be applied to hundreds of specimens on one slide, tissue arrays provide a cost-effective and time-saving platform for high-throughput screening of potential biomarkers. Furthermore, the integration of tissue array data with clinical information allows researchers to correlate molecular findings with patient outcomes, offering insights into disease progression, treatment response, and survival rates. This correlation has profound implications for precision medicine, where treatment decisions are tailored to the individual molecular profile of a patient’s tumor.
In addition to cancer research, tissue arrays are increasingly used in studying a wide range of diseases such as cardiovascular disorders, neurological conditions, infectious diseases, and inflammatory processes. By including normal, diseased, and treated tissue samples within a single array, scientists can investigate pathological mechanisms and therapeutic effects in a controlled, comparative framework. For example, in neuroscience, tissue arrays have been utilized to explore protein expression in brain tissues affected by Alzheimer’s disease, Parkinson’s disease, and other paraffin tissue block for quality control conditions. Similarly, in immunology, arrays help researchers study immune responses in tissues infected by viruses or bacteria, allowing for simultaneous assessment of cytokine expression or immune cell infiltration. The versatility of tissue arrays extends to pharmacological research as well, where drug efficacy and toxicity can be evaluated across different tissue types using the same experimental setup. This application is particularly valuable in preclinical testing, where rapid and cost-effective screening of candidate drugs is essential.
One of the key strengths of tissue arrays lies in their compatibility with multiple molecular analysis techniques beyond traditional histopathology. In addition to immunohistochemistry, tissue arrays can be used for in situ hybridization (ISH), fluorescence in situ hybridization (FISH), and even next-generation sequencing (NGS)-based assays, depending on the preservation quality of nucleic acids within the paraffin-embedded samples. This flexibility allows researchers to assess not only protein expression but also DNA mutations, RNA transcripts, and epigenetic modifications in a spatially preserved tissue context. For example, FISH assays performed on tissue arrays can identify chromosomal aberrations, gene amplifications, or translocations across hundreds of samples in a single experiment. Similarly, RNA in situ hybridization enables visualization of gene expression patterns within tissue architecture, providing valuable information about the localization of specific transcripts. The integration of these molecular techniques with tissue array platforms supports comprehensive, multidimensional analyses that bridge histopathological and genomic data, enhancing our understanding of disease biology.
Despite their numerous advantages, tissue arrays also come with certain limitations that must be acknowledged. One concern is the issue of tissue heterogeneity, particularly in tumors where different regions may exhibit variable cellular composition and molecular characteristics. Since tissue cores represent only a small portion of the donor block, they may not capture the full diversity of the tissue’s pathological features. To address this, researchers often include multiple cores from different regions of the same specimen to improve representativeness. Another limitation relates to the potential loss of antigenicity or nucleic acid integrity in archived samples, especially those that have been stored for long periods. Proper storage and handling of FFPE tissues are crucial to ensure reliable results. Additionally, the technical precision required in constructing arrays can pose challenges; slight misalignment during embedding or sectioning may lead to data inconsistencies. Despite these issues, advances in automated arrayers and digital pathology systems have significantly improved the accuracy and reproducibility of tissue array construction and analysis.